Zekiye Korkmaz

Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.

T. Petrich, Leticia Quintanilla-Martı́nez, Zekiye Korkmaz et al. · Clinical Cancer Research · 2006 · 42 citations

Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [⁶⁸Ga]MHLL1

Laura Langer, Annika Hess, Zekiye Korkmaz et al. · Theranostics · 2021 · 39 citations · Full text

Synthesis and analysis of 2-[211At]-l-phenylalanine and 4-[211At]-l-phenylalanine and their uptake in human glioma cell cultures in-vitro

G.-J. Meyer, Almut Walte, Siva R. Sriyapureddy et al. · Applied Radiation and Isotopes · 2010 · 30 citations

Neuro-oncology, Anti-cancer Agent, Radiation Oncology +6

In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin

T. Petrich, Zekiye Korkmaz, Doris Krull et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 27 citations

Hematological Malignancy, Cell Therapy, Gemtuzumab Ozogamicin +9

Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a⁴⁵Ca autoradiographic study

M. Javad Mirzayan, Petra M. Klinge, Sven Ude et al. · Neurological Research · 2008 · 15 citations